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Abstract
In 2008, an unusual strain of methicillin-sensitive Staphylococcus aureus (MSSA68111), producing both Panton-Valentine
leukocidin (PVL) and toxic shock syndrome toxin-1 (TSST-1), was isolated from a fatal case of necrotizing pneumonia.
Because PVL/TSST-1 co-production in S. aureus is rare, we characterized the molecular organization of these toxin genes in
strain 68111. MSSA68111 carries the PVL genes within a novel temperate prophage we call FPVLv68111 that is most similar,
though not identical, to phage FPVL – a phage type that is relatively rare worldwide. The TSST-1 gene (tst) in MSSA68111 is
carried on a unique staphylococcal pathogenicity island (SaPI) we call SaPI68111. Features of SaPI68111 suggest it likely
arose through multiple major recombination events with other known SaPIs. Both FPVLv68111 and SaPI68111 are fully
mobilizable and therefore transmissible to other strains. Taken together, these findings suggest that hypervirulent S. aureus
have the potential to emerge worldwide.
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Introduction
Staphylococcus aureus infections range in severity from superficial
abscesses to complicated deep soft tissue infections and toxic shock
syndrome (TSS) [1,2]. The pathogenesis of these diverse infections is
attributed to multiple extracellular toxins including the Panton-
Valentine leukocidin (PVL) and Toxic Shock Syndrome Toxin 1
(TSST-1). PVL has been epidemiologically linked to severe commu-
nity-associated MRSA (CA-MRSA) infections [3,4] while TSST-1
clearly mediates shock and organ failure in staphylococcal TSS [5,6].
Historically, a single strain of S. aureus rarely produced both
PVL and TSST-1. However, in 2005, one British report
documented the TSST-1 gene in 4 of 30 PVL-positive isolates
[7], one of which was associated with severe pneumonia [7].
Subsequently, twenty S. aureus isolates (15 MSSA; 5 MRSA)
harboring both PVL and TSST-1 toxin genes were reported in the
United Kingdom [8]. Of these, seventeen strains were from one of
three clonal complex (CC) lineages: twelve (60%) belonged to
lineage CC30 and five were either CC5 or CC22. The other three
strains could not be assigned to any known clonal complex. Four
of the 5 MRSA strains (80%) were multi-drug resistant. Eight of
these isolates (40%) were associated with serious diseases including
pneumonia, empyema, deep-seated abscesses and toxic shock.
Nine patients presented with abscess or other skin infections [9].
One fatal case of necrotizing pneumonia was also reported in a 14-
year-old child who presented initially with sore throat and pyrexia,
and then deteriorated rapidly, developing hypotension and
multiple organ failure [9].
In this report, we describe the genetic makeup of the
hypervirulent TSST-1/PVL co-producing MSSA isolated from
this fatal case (MSSA68111; CC30) [9]. Our results demonstrate
that MSSA68111 produces both PVL and TSST-1 toxins.
Further, its PVL-carrying phage and TSST-1-carrying pathoge-
nicity island (SaPI) are both unique and not heretofore reported in
S. aureus. Both novel genetic elements are fully mobilizable,
suggesting that the emergence and dissemination of hypervirulent
S. aureus may be forthcoming worldwide.
Materials and Methods
S. aureus
MSSA68111 was from a fatal case of necrotizing pneumonia in a
14-year-oldchildwhopresentedinitiallywithsorethroatandpyrexia,
and then deteriorated rapidly, developing hypotension and multiple
organ failure [9]. It is penicillin-resistant but sensitive to erythromy-
cin, tetracycline, vancomycin and linezolid [8]. It is of the MLST-
C C 3 0l i n e a g e( s e q u e n c et y p eS T 7 7 6 ,at r i p l el o c u sv a r i a n to f
ST30;spa type t399), harbors agr type 3 and is gene-positive for sec but
negative for sea, seb, seg, seh and sei [8] (and unpublished data). TSST-
1-positiveMSSAstrainswerereportedasbeinghighlyassociatedwith
the CC30 lineage, which is a very common genotype worldwide and
is the most predominant lineage reported in the United Kingdom,
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(American Type Culture Collection) harbors the PVL genes (herein
referred to as lukF-PV and lukS-PV) and produces LukF/S-PV
[14,15]. A clinical CA-MRSA isolate, strain 04-014, produces TSST-
1 but not PVL [16]. Two clinical USA300 MRSA strains, 934814
and 09-301-02119, were from patients with septic arthritis and fatal
post-influenza pneumonia, respectively. MSSA laboratory strain
RN4220 is a restriction-deficient derivative of the 8325-4 strain [17].
MRSA strain MW2 (USA400) was originally isolated from a 16-
month-old girl with fatal septicaemia [18].
S. aureus were routinely cultured in Mueller-Hinton II broth; no
differences in growth rates were observed. For analysis of toxin
production, washed S. aureus from overnight cultures were diluted
to 1-3610
6 CFU/mL in fresh media and grown at 37uCi n5 %
CO2 with shaking (200 rpm) for 20 h (yields 1-4610
9 CFU/mL).
Culture supernatant fluids were filter sterilized and frozen at
270uC until assayed for toxins.
Toxin assays
TSST-1 and PVL were measured by ELISA [16,19]. Alpha-
hemolysin activity was measured by lysis of rabbit erythrocytes
[19]. All assays were run in duplicate or triplicate and included 2–
3 biological replicates.
PVL induction and Phage DNA Purification
Exponential phase S. aureus (OD600=0.8) in CYPG (Casamino
acids 10 g; yeast extract, 10 g; NaCl, 5 g;0.5% glucose and 0.06 M
phosphoglycerate in 1 L) were treated with 1 mg/ml mitomycin C
and cultured for 3.5 hrs at 32uC with slow shaking (80 rpm). The
culture was centrifuged (8,000Xg, 20 min, 4uC) and the filtered
(0.22 um) supernatant was treated with DNase I (0.5 U/ml) and
RNase A (0.25 mg/ml) at 37uC for 1 hr. After centrifugation
(20,000Xg, 1 hr, 4uC), the pellet was resuspended in TES Buffer
(100 mM Tris pH 8, 100 mM EDTA, 1% SDS) in the presence of
proteinase K (1 mg/ml). After 30 min at 55uC, the DNA was
extracted twice with phenol-chloroform and precipitated with two
volumes of cold 100% ethanol. The DNA pellet was washed twice
with 70% ethanol and resuspended in 100 ul H2O. The junction
sequence of induced PVL phage in MSSA68111 was PCR-
amplified using an inverse primer set targeting the integrase (int)
(PVL-int: AGCAATTATGAAAAGGGT-AGGACA) and PVL
(lukF-PV: AGTTGATTGGGAAAATCATACAGTT) genes.
Southern Blot Analysis of PVL Phage DNA
Restriction enzyme digestion of PVL phage DNA and Southern
blot analysis was performed using standard methods. Specific DNA
fragments were detected using a chemiluminescence system
(North2South, Thermo Fisher, Rockford, IL). lukS-PV probe was
PCR-amplified using the primers lukS-left: TGTATCTCCT-
GAGCCTTTTTCA and lukS-right: CAGACAATGAATTACC-
CCCATT.
Chromosomal Localization of PVL Phage
Bacteria were grown in CYPG to OD625=0.6. Genomic DNA
was extracted with a commercial kit (Qiagen). The chromosomal
insertion site of PVL phage was PCR-verified with the primer pair
phiPVL-reverse (to the lukF-PV gene: AGTTGATTGGGAA-
AATCATACAGTT) and phiPVL-forward (to a conserved
hypothetical protein: TCCATCGTTTGAATTGCTTG).
Tst-SaPI induction and Genomic DNA Purification
Bacteria were grown in CYPG to OD625=0.15, centrifuged,
resuspended in CYPG-Phage Buffer (1:1) at a density of
OD625=0.05 and infected with phage 11 or phage 80a at a
multiplicity of 6:1 or 3:1. Cultures were grown at 32uC with slow
shaking (80 rpm) for 1 hr. Samples (8 ml) were centrifuged and
the bacterial pellet resuspended in 100 ul GET buffer (0.1 M
glucose, 0.01 M EDTA and 0.05 M Tris-HCl, pH 8) and lysed
with lysostaphin (0.5 mg/ml) in the presence of RNaseA (0.5 mg/
ml) at 37uC for 1 hr. The lysate was further digested with
proteinase K (0.5 mg/ml) at 55uC for 3 hrs. Genomic DNA was
then extracted with a commercial kit (Qiagen). The junction
sequence of induced SaPI68111 was PCR-amplified using an
inverse primer set targeting the sel (CTGGACCTACAT-
CGCCGTTA) and SaPI-integrase (GTGTTGGATGAGCAAT-
TACCAA) genes. The chromosomal insertion site of SaPI68111




DNase-treated total RNA (1 mg) was reverse transcribed using
M-MuLV enzyme (New England Biolab, Ipswich, MA) and
random hexamer primers and dNTPs (Invitrogen, Carlsbad, CA).
cDNA was diluted fifty-fold in nuclease-free water and used for
real-time PCR performed with a 7500 Fast Real-time PCR System
(Applied Biosystems, Carlsbad, CA) using the RT
2 real-time
SYBR green/Rox PCR master mix (SuperArray, Frederick, MD)
and primer sets: (1) LukS-PV-up:TGTATCTCCTGAGCCTTT-
TTCA and LukS-PV-down: CAGACAATGAATTACCCC-
CATT (Accession: YP_494079); (2) RecA-up:TGCAGAACA-
GCTTAAACAAGGA and RecA-down:ACTCTAAATGGT-
GGTGCCACTT (Accession: L25893); (3) gyrase-up:ATGTAG-
CAAGCCTTCCAGGTAA and gyrase-down:CAGAGTCCCC-
TT-CGACTAAGAA (Accession: YP_492727); (4) TSST-1-up:-
TCGCTACAGATTTTACCCCTGT and TSST-1-down:CG-
TTTGTAGATGCTTTTGCAGT (Accession: NC_002745). Rel-
ative gene expression was determined using the 2
-A ¨A ¨Ct method
[20]. The fold change in expression of the gene of interest was
normalized to the internal control gene (Gyrase B) and made
relative to the calibrator sample (Time=0).
Results
1. Toxin Production
In our initial studies, we compared by ELISA the levels of PVL
and TSST-1 in 20-hr culture supernatant from S. aureus strain
68111 with known PVL- (ATCC49775 and a clinical MRSA
isolate 934814) or TSST-1-producing (04-014) isolates (see details
in Materials and Methods section) [14–16]. Our analysis showed
that MSSA68111 produces 160.24 ng/mL PVL in 20-hr culture,
which is significantly lower than that from the well-characterized
PVL-producing MSSA strain ATCC49775 (Table 1), but
comparable to that obtained from a clinical strain 934814
(USA300) (Table 1). Similarly, the production of TSST-1 in
MSSA68111 is also relatively low, yielding 716.5 ng/mL, whereas
the TSST-1 positive clinical isolate, strain 04-014, had a strongly
positive ELISA result, producing 6739 ng/mL (Table 2).
Further, various hemolytic activities of MSSA68111 were
assessed. When 20-hr culture supernatant of MSSA68111 was
assayed for alpha-toxin with rabbit erythrocytes, a titer of
246 HU/ml was obtained (Table 3). With the same supernatant,
no ‘‘hot-cold’’ hemolysis could be detected on sheep erythrocytes,
indicating that staphylococcal beta-toxin is either absent or present
only in a small amount in this strain (data not shown). Last, for the
delta-hemolysin, we adapted a quick-screening methodology
established by Herbert [21] and Traber [22] which takes
PVL/TSST-1 Co-Production in S. aureus
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beta-hemolysin. Thus, by streaking test strains perpendicularly to
strain RN4220, which produces only beta-hemolysin, one can
visually identify delta-hemolysin production in test strains as an
enhanced area of hemolysis where the two strains come in near to
one another. As shown in Figure 1, MSSA68111 produces a
significant amount of delta-hemolysin, indicated by the increased
area of hemolytic activity when it nears strain RN4220. This same
assay also can be used to detect alpha-hemolysin production in test
strains since alpha-hemolysin activity is inhibited by beta-
hemolysin. Using this technique, alpha-hemolysin production by
MSSA68111 was also demonstrated (Figure 1). The moderate
alpha- and delta-hemolysin activities, as well as production of
TSST-1 (albeit in low amounts) suggested MSSA68111 carries an
intact Agr/RNAIII operon.
Having confirmed that MSSA68111 does indeed produce both
TSST-1 and PVL – a phenomenon that is rare among S. aureus
strains - we investigated the genetic organization of these genes in
this unique clinical isolate.
2. Characterization of PVL-Carrying Phage in MSSA68111
2.1. PVL phage lineage and mobility. The genes for PVL
are commonly carried by one of six lysogenic bacteriophages
[18,23–27] having two distinct phage-head morphologies:
icosahedral (FPVL and F108PVL) or elongated (FSLT,
FSa2 mw, FSa2958 and FSa2usa) [18,23–27]. Ma et al.
recently reported a 2-step PCR-based scheme for characterizing
S. aureus PVL-encoding phages [28]. The first round of PCR
identifies the morphological group using primers specific to the
gene lineage between lukS-PV and the tail gene. The second round
of PCR establishes the phage type using primers recognizing
phage-specific structures. With this approach, we determined that
MSSA68111 carries an icosahedral-head type PVL-encoding
phage, because PCR-1 (amplifying phage portal and tail genes)
and PCR-3 (amplifying lukS-PV to group-specific tail gene) were
positive, whereas PCRs-2 and -4 (amplifying genes specific for
elongated-head type phage) were negative. Further, our PCR-5
result (targeting to phage specific structures) showed a PCR
product of 1411 bps suggesting that the PVL-carrying phage in
MSSA68111 belongs to the FPVL, but not F108 PVL, lineage.
To assess the mobility of this PVL phage, we treated
MSSA68111 with mitomycin C since it induces the lytic cycle of
many temperate phages. After 2–4 hrs, the culture visibly cleared,
suggestive of phage-meditated bacterial lysis. To confirm this,
phage DNA was purified and amplified with an inverse primer set
which targets the integrase and lukF-PV genes. The resultant PCR
product (Figure 2A) suggested that the PVL-carrying phage in
MSSA68111 did indeed become lytic following mitomycin C
treatment. Commercial sequencing of the PCR product with
subsequent GenBank BLAST searching demonstrated that the attP
junction sequence of MSSA68111’s PVL-carrying phage was
similar to that in other known PVL-phage lineages (Figures 2B,
2C), demonstrating that the nucleotide sequences of the integrase
as well as the chromosomal integration site are highly conserved
among different PVL-carrying phages.
We next compared the restriction profiles of the mitomycin C-
elicited PVL-phage genomic DNA from MSSA68111 and
ATCC49775 (carries FPVL [25]) by Southern blot analysis using
a lukS-PV-specific probe. Identical hybridization patterns were
seen following XbaI, but not SpeI, digestion (Figures 3A, 3B). Thus,
the PVL-carrying bacteriophage in MSSA68111 has a similar, but
not identical, restriction profile to FPVL. We propose the name
FPVLv68111 for this FPVL variant. Last, sequence analysis of
Table 1. PVL in 20-hr bacterial culture supernatants.





Table 2. TSST-1 in 20-hr bacterial culture supernatants.




Figure 1. Alpha- and delta-hemolysin activities of S. aureus
strain 68111. A plate-based screening method that capitalizes on
beta-hemolysin-mediated effects on alpha- and delta-hemolysin
activities was used to examine extracellular production of these toxins
in MSSA68111. For this, beta-hemolysin-producing S. aureus strain
RN4220 was streaked vertically on sheep blood agar. MSSA68111 (top)





+ [bottom]) were then streaked
perpendicularly to RN4220. Hemolysis was assessed after 24 hrs
incubation at 37uC (no cold shock applied). At the junction between
the test strains and RN4220, alpha-hemolysin activity is inhibited
(arrowhead); the presence of delta-hemolysin is observed as an
enhanced area of hemolysis (arrows).
doi:10.1371/journal.pone.0027246.g001
Table 3. alpha-hemolysin in 20-hr bacterial culture
supernatants.





PVL/TSST-1 Co-Production in S. aureus
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27246LukSF-PV genes in MSSA68111 indicated they belonged to the
H1 variant with an H176R amino acid substitution. This
information is consistent with the work of O’Hara et al [29],
showing that H variants of LukSF-PV genes were mostly carried by
mecA
- S. aureus isolates found mainly outside the United States.
2.2. Characterization of FPVLv68111 integration site. To
investigate the chromosomal insertion site of FPVLv68111, we
performed PCR based on the known phage PVL insertion sites in
the other strains (e.g., ATCC49775, MW2) using primers that
hybridize to the lukF-PV gene and to a hypothetical gene
(Figures 4A, 4B). Commercial sequencing of the resultant PCR
product revealed a 29 nucleotide region of the FPVLv68111 attR
site (lysogenic form) that was identical to attP sequence of
FPVLv68111 (lytic form; Figure 2C), and the position at which
the phage insertsinto the hypothetical gene of the host chromosome
was well conserved among currently known PVL-producing strains
(Figure 4C).
3. Characterization of Tst-Carrying SaPI in MSSA68111
3.1. Gene organization of sel-sec-tst. Several S. aureus
exotoxin genes cluster within pathogenicity islands (SaPIs) [30,31].
MSSA68111 was reported to be gene-positive for the exotoxins
SEL, SEC and TSST-1 [9] (coded for by sel, sec and tst,
respectively) which are commonly clustered in SaPI1 [32], SaPI2
[30,33], SaPIn1/m1 [34] or SaPIbov [35,36]. To investigate the
organization of these toxin genes in MSSA68111, PCR was
performed using primers based on the known SaPIn1 and SaPIbov
sequences. The size of the PCR products and corresponding
sequencing data demonstrated that sel-sec-tst were clustered
sequentially in MSSA68111. Like SaPIn1 or SaPIm1, the sec
and tst genes are approximately 2 kb apart and in opposite
orientations (data not shown).
3.2. Mobility of tst-carrying SaPI by helper phage. In the
excision-replication-packaging (ERP) cycle, temperate bacterio-
phages can induce excision and replication of SaPIs and can
package the ensuing DNA into special small phage-like particles
using proteins supplied by the helper phage. Using genomic DNA
electrophoresis [32], we assessed two common staphylococcal
helper phages, phage 80a or phage 11, for their ability to
mobilize the tst-carrying SaPI in MSSA68111. We did not
observe the typical SaPI-specific band on a stained agarose gel
containing bacterial genomic DNA following helper phage
induction (data not shown), suggesting that this SaPI did not
undergo massive helper phage-mediated ERP.
To increase the sensitivity of detection of ERP, we used real-time
qPCR-based methods to quantify the copy number of tst-SaPI within
MSSA68111 host cells (Figure 5). Tst and gyr were the target and the
reference genes, respectively. Preliminary studies (data not shown)
demonstrated that S. aureus genome contained only one copy each of
tst and gyr and that the amplification efficiencies of these genes
(calculated from the slope of the standard curve generated with serial
dilutions of cDNA template for each gene) were equivalent (1.92 vs
1.90, respectively). Thus, the copy ratio of tst to gyr before SaPI
induction was 1. In contrast, following superinfection with phage 11,
the tst amplification curve was left-shifted indicating increased copy
number of the tst gene compared to the gyr gene. The tst-carrying
SaPI copy number relative to the reference gene gyr could be given by
the ratio: [(Etst)
DCttst(control-treated)]/[(Egyr)
DCgyr(control-treated)][ 3 7 ] .A s
shown in Figure 5, after 1.5 hrs of exposure to helper phage 11 at
MOI of 3:1 or 6:1, the relative tst-carrying SaPI copy number in
MSSA68111 was dose-dependently increased 5.6-fold and 17.2-fold,
respectively.
In contrast, no excised form of tst-carrying SaPI was found
following UV- or mitomycin C treatment or phage 80a induction
Figure 2. DNA sequence of the attP junction of MSSA68111 PVL phage. (A.) PCR was performed with an inverse primer set using mitomycin
C-elicited phage genomic DNA from MSSA68111 as a template. PCR products were separated by agarose gel electrophoresis and stained with
ethidium bromide. (B.) Nucleotide sequence of the 68111 PCR product was determined. The sequence originating from PVL phage integrase is
printed in upper-case letters, and that derived from lukF-PV gene is shown in italic letters, and twenty-nine base pairs of the core attP sequence are
bolded and underlined. (C.) This attP sequence of MSSA68111 PVL phage was compared to that from other published PVL-carrying phages.
Nucleotide variations were underlined.
doi:10.1371/journal.pone.0027246.g002
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by the above qPCR method (data not shown). We conclude that
the excision of tst-SaPI in MSSA68111 is highly phage 11-specific.
3.3. Characterization of the integrase of tst-carrying
SaPI. To determine the integrase sequence and chromosomal
integration site of the tst-carrying SaPI in MSSA68111, an
outward-directed PCR on genomic DNA was conducted
following helper phage 11 induction (Figure 6A). Sequencing of
the PCR product showed a 15-bp direct repeat occurs at the
junction between sel and integrase as indicated in Figure 6. The att
core (59-TCCCGCCGTCTCCAT-39) matches the core att site for
several other SaPIs (e.g., SaPIm4, SaPImw2). Further comparison
of the integrase sequence as well as the chromosomal integration
site of the tst-carrying SaPI in MSSA 68111 with those from the
previously characterized SaPIm4 and SaPImw2 showed 96% and
87% identity of intergrase genes, respectively, and the same
chromosomal insertion site of all three, at 39 end of ssrP (Figure 6B).
In contrast, the organization of accessory genes in SaPI68111
including sel, sec, and tst genes, is most closely related to that of
SaPIn1.
Because of these findings, a complete genome sequencing of the
tst-carrying SaPI in MSSA68111 was conducted using a PCR and
bi-directional primer walking-based approach. In all, the 16,422-
bp SaPI68111 (Accession: JN689383) was determined to have 21
ORFs potentially encoding proteins over 50 amino acids in length,
3 of which encoded staphylococcal exotoxins (sel, sec, and tst), and
many of which have homologs in SaPIM4, SaPIM1, SaPIbov1
and SaPI2 as indicated in Figure 7A, 7B and Table 4. These data
suggest that the evolutional history of SaPI68111 probably
includes at least one major recombination event with these SaPIs
or other similar elements. Also interestingly, we found that the
predicated product of stl in SaPl68111, a SaPI master repressor,
shares 64% similarity (over 298 amino acids) to a hypothetical
phage repressor protein of Staphylococcus haemolyticus bacteria
(Accession: YP_254016; Figure 8). Particularly, the putative N-
terminal HTH (helix-turn-helix) motif of SaPI68111-stl repressor
belongs to the HTH -XRE-family of proteins and shows a high
degree of 80% similarity (as much as 65% identity) to the HTH
motifs of repressor protein of Staphylococcus haemolyticus but not to
HTH motifs of most S. aureus (Figure 8). These data have led to the
supposition that this gene was acquired by S. aureus through
horizontal transfer from Staphylococcus haemolyticus during co-
colonization of human skin [38].
4. Transcription of PVL and TSST-1
Increased PVL transcription after mitomycin C treatment has
been attributed to an increase of phage copy number following
phage excision and replication [39]. Consistent with this, our
quantification of lukS-PV mRNA and DNA in MSSA68111 by
real-time PCR confirmed that mitomycin C treatment resulted in
a marked increases of both PVL transcript (Figure 9A) and PVL-
DNA copy number (Figure 9B). Mitomycin C also activates recA-
mediated autocleavage of phage repressors and resumption of the
lytic cycle [40,41]. Thus increased recA expression following DNA
damage temporally coincides with increase phage-encoded gene
transcription. Consistent with this notion, we observed a modest
increase of recA expression in MSSA68111 following mitomycin C
treatment (Figure 9A).
In contrast to PVL, mitomycin C treatment induced only a
slight increase in TSST-1 mRNA and no excised form of tst-
SaPI68111 was detected (Figures 9A, 9B). However, the
abundance of both tst transcripts as well as the tst gene copy
Figure 3. Southern blot analysis of PVL phage genomic DNA from strain 68111 and strain ATCC49775. Phage DNA from MSSA68111
(Lanes designated ‘‘6’’) and from strain ATCC49775 (Lanes ‘‘A’’) was digested with either XbaI (A.)o rSpeI (B.). In both A and B, the panels on the left
are photographs of ethidium bromide-stained gels; the panels on the right are Southern blots hybridized with the lukS-PV probe. 1 kb DNA ladders
(Lanes ‘‘L’’) are shown. The lukS-PV probe hybridized to identical 2 kb fragments in XbaI -digested phage DNA from both strains (A, arrow) whereas
SpeI-digestion produced different sized lukS-PV fragments (B.).
doi:10.1371/journal.pone.0027246.g003
PVL/TSST-1 Co-Production in S. aureus
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phage 11 (Figures 9C, 9D). These results were observed in the
absence of a recA/SOS response (Figure 9C). Similarly, PVL genes
at both the DNA and mRNA levels also remained unchanged by
phage 11 treatment (Figures 9C, 9D). Thus, tst-SaPI68111
induction (excision and replication) is positively correlated with
TSST-1 transcription and does not involve the recA/SOS
response.
Discussion
Co-production of SEC, TSST-1 and PVL in MSSA68111 was
proposed to contribute to the rapid demise of the young British
patient with hemorrhagic pneumonia [9]. Further, the recent
report of severe infections due to three separate clonal lineages of
S. aureus co-producing TSST-1 and PVL [8] portends a possible
emergence of hypervirulent S. aureus worldwide.
In addition to its epidemiologic association with fatal pneumo-
nia, MSSA68111 is also of considerable interest from a purely
genetic point of view. For unknown reasons, certain combinations
of staphylococcal toxins are rarely present in the same clinical
isolate. This is true for TSST-1 with staphylococcal enterotoxin B
(SEB) and for TSST-1 with PVL. Thus MSSA68111 is a
significant deviation from the norm. As such, it provides a unique
opportunity to investigate the mechanisms responsible for this
phenomenon and to gain insight into likely emergence and
dissemination of the next S. aureus ‘‘superbug’’.
We confirmed that MSSA68111 produced both TSST-1 and
PVL. PVL production by MSSA68111 was comparable to other S.
aureus clinical isolates we have tested [16], however the level of
TSST-1 was low. The relatively low level of TSST-1 in
Figure 4. DNA sequences of integration site of PVL phage in bacterial genome. (A.) PCR was performed with primers, as shown in (B.)
using bacterial genomic DNA as templates. PCR products were separated by agarose gel electrophoresis and stained with ethidium bromide. (C.) The
sequence of PCR product from MSSA68111 was determined and is shown relative to other strains carrying PVL phage. The sequence originating from
the phage PVL genomic DNA including lukF-PV gene is printed in upper-case letters, and that derived from the bacterial chromosome, a conserved
hypothetical protein, is shown in italic letters. Twenty-nine base pairs of core attR sequence are bolded and underlined. Nucleotide variations are
underlined. 1.FPVLv68111; 2. WPVL (strain ATCC49775 [25]); 3. WPVL108 (Accession: AB243556); 4. W2958 PVL (Accession:AP009363); 5. WSLT
(Accession: CP000255); 6. WSa2 MW (Accession: BA000033).
doi:10.1371/journal.pone.0027246.g004
Figure 5. Induction (excision/replication) of tst-SaPI elements
by phage11. Following superinfection with phage 11 as described in
Materials and Methods, total genomic DNA was purified and analyzed
for tst and gyr genes by real-time PCR. Relative copy numbers of tst
versus gyr are presented. Data are means6SD (n=4); p*,0.05;
p**,0.01 vs control (before F11 treatment) (paired t-test).
doi:10.1371/journal.pone.0027246.g005
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RNAIII system since both alpha- and delta-hemolysins were
produced. In addition, real-time RT-PCR showed that RNAIII
transcripts in MSSA68111 were comparable to those from MRSA
strains FPR3757 (USA300) and MW2 (USA400) (data not shown).
Expression of RNAIII was inversely related to expression of spa
gene in wild-type MSSA68111 but not in its isogenic RNAIII
mutant (data not shown). The low levels of TSST-1 and PVL are
also not an artifact of the ELISA-based detection system since their
respective nucleotide sequences in MSSA68111 are highly similar
to those of other strains (data not shown).
Although extensive studies have been conducted by others, the
exactmechanismresponsibleforthewidevariationintheamountof
TSST-1 produced by different strains of S.aureus,is still unknown. A
studyof 152 TSST-1-positive MRSA isolates byNagao et alshowed
that differences inTSST-1production (up to170-fold)isnotdirectly
correlatedwith the allelic variations ofthe agr[42]. In addition, their
sequencing of the promoter region of the tst gene, the entire sigma
factor B and sar loci revealed no relevant nucleotide changes among
these strains [42]. Thus it is likely that the low level of TSST-1 in
MSSA68111 may not simply be explained by one mechanism, but
rather multiple known or unknown complex interconnected
regulatory systems are operative. In addition, the low level of
TSST-1 production in MSSA68111 could be a consequence of co-
production of both TSST-1 and PVL toxins, as other investigators
have shown that some toxins function as autorepressors or negative
regulators of other exoproteins [43].
Bacteriophages mediate dissemination of genes and hence
bacterial diversity. We show that the PVL-carrying phage from
MSSA68111 (FPVLv68111) is a variant of icosahedral-head type
phage FPVL. The basis for this conclusion is that FPVL and
FPVLv68111 share similar phage structural genes, identical XbaI
restriction profiles and phage integration sites, but different SpeI
restriction fragment profiles. Among clinical isolates that have
been studied, FPVL is relatively rare in the United States but is
more prevalent in Europe [28]. In contrast, the elongated-head
type PVL-phage, represented by FSa2usa, is currently dominant
worldwide [44]. These findings suggest that FPVL and
FPVLv68111 might have evolved from a common ancestor and
that genetic drift may have occurred in one or both. Features
unique to FPVLv68111 may have permitted MSSA68111 to
acquire the genes for TSST-1 production.
Figure 6. Sequence analyses of tst-carrying SaPI in MSSA68111. (A.) Junctional sequence of circulated SaPI (lytic form) following helper
phage 11 induction. Sel coding region is bolded; integrase of tst-SaPI is shown in italic letter and 15 base pairs of core attP are bolded and underlined.
Other intergenic regions are presented in lower-case font. A schematic illustration of the PCR strategy used to amplify this junctional region is shown
in (B.). (C.) Sequence of integration site of tst-SaPI (lysogenic form) in bacterial genome. SsrP coding region is bolded, integrase of tst-SaPI is shown in
italic letter and 15 base pairs of core attL are bolded and underlined. Other intergenic regions are presented in lower-case font. A schematic
illustration of the PCR strategy used to amplify the integration site of tst-SaPI is shown in (D.).
doi:10.1371/journal.pone.0027246.g006
Figure 7. Illustrative representation of pathogencity island 68111 (SaPI68111). Arrows represent the location and orientation of open
reading frames (OFRs), which were determined using the NCBI-GLIMMER program and by the relative position of ORFs within the island and/or
similarity of the predicted gene products. (A.) An illustrative diagram of the SaPI68111 genome with different functional annotations presented at the
bottom of the figure. (B.) A summary diagram of the homology regions between SaPI68111 and other close-related SaPIs. SaPIM4 (thick line), SaPIM1
(triple lines) and SaPIbov1 or SaPI2 (thin line).
doi:10.1371/journal.pone.0027246.g007
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27246Figure 8. Amino acid alignment of predicted stl from MSSA68111 and hypothetical phage repressor protein SH2101 from
Staphylococcus haemolyticus (Accession: YP_254016.1). The protein sequences were aligned by using the CLUSTAL alignment program. The
Helix-turn-helix XRE-domain is highlighted in the black box. The asterisk denotes a position at which the two sequences have the same amino acid.
Dots indicate the degree of homology when there is not complete sequence conservation.
doi:10.1371/journal.pone.0027246.g008
Table 4. Relationships between SaPI68111 genes and those of other SaPIs.
SaPI68111 Mu50 RF122 RN3984 MW2 Annotation or Function
SaPIM4 SaPIm1 SaPIbov1 SaPI2 SaPIMW2
orf1 int 96(98) 87(100) Integrase
orf2 stl SaPI master repressor
orf3 str 88(91) 88(91) Regulatory protein
orf4 HP 82(92) 83(91) Hypothetical protein
orf5 HP 97(88) 95(88) 96(88) Hypothetical protein
orf6 HP 96(100) 93(100) 96(100) 90(100) Hypothetical protein
orf7 pri 96(100) 93(69) 93(69) 93(69) Similar to DNA primase
orf8 rep 99(100) Similar to replication initiation protein
orf9 HP 99(100) Hypothetical protein
orf10 HP 99(100) Hypothetical protein
orf11 HP 96(100) 96(100) 96(100) 95(100) Hypothetical protein
orf12 HP 97(100) 97(100) 97(100) 96(100) Hypothetical protein
orf13 cp 98(100) 98(100) 94(100) 98(100) Capisid size determinant
orf14 cp 99(100) 99(100) 96(100) 100(100) Capisid size determinant
orf15 cp 96(100) 96(100) 97(100) 95(100) Capisid size determinant
orf16 HP 96(100) 96(100) 98(100) 96(100) Hypothetical protein
orf17 terS 98(100) 98(100) 94(100) 97(100) 90(27) Terminase small subunit
orf18 tst 100(100) 100(100) 100(100) Toxic shock syndrome toxin-1
orf19 HP 100(100) 77(82) Hypothetical protein
orf20 sec3 99(100) 95(100) 97(100) Staphylococcal enterotoxin type C3
orf21 sel 100(100) 100(100) 99(100) Staphylococcal enterotoxin L
Note: The similarities of SaPI68111 with other close-related SaPIs were determined with BLAST. Percentage of identity to corresponding gene in SaPI68111a n d
percentage of query coverage (in the bracket) were given in the table. Blank area indicated no corresponding genes.
doi:10.1371/journal.pone.0027246.t004
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because integrated prophages are defective. However,
FPVLv68111 is fully mobilized as part of a recA-mediated SOS
response and its induction results in enhanced lukS-PV transcrip-
tion. These findings indicate functional FPVLv 68111 can be
readily transmitted to other S. aureus strains.
Staphylococcal pathogenicity islands (SaPIs) are other mobile
genetic elements responsible for inter- as well as intra-genic spread
of exotoxin genes. MSSA68111 carries a unique SaPI which we
have designated SaPI68111. Like SaPIn1/m1, SaPI68111 carries
a central region of sequence identity encompassing sel-sec-tst in the
classical arrangement. However, unlike all known tst-carrying
SaPIs, SaPI68111 is inserted in an att site close to the ssrP gene
with a 15-bp repeat. Further, the integrase gene in SaPI68111
appears related to SaPImw2 and SaPIm4, but not to SaPIn1/m1
or any other known tst-carrying SaPIs. Most interestingly, the
predicated stl gene in SaPI68111, a master regulator for SaPI EPR
cycle, does not share any homology with any published sequence
in S. aureus, but has 64% similarity with a hypothetical phage
repressor of Staphylococcus haemolyticus. This unique combination of
genetic characteristics suggests that SaPI68111 probably arose
following at least one major recombination event with several
SaPIs or other similar elements, whereas the regulatory gene (e.g.,
stl gene) might be acquired by S. aureus through horizontal transfer
from other species (e.g., Staphylococcus haemolyticus) during co-
colonization or infections.
Induction of SaPIs excision/replication requires specific helper
phages, and in MSSA68111, chromosomal excision of tst-
SaPI68111 was driven solely by helper phage 11. This finding is
unique in that most SaPIs are specifically induced by phage 80a
alone or in combination with phage 11. To our knowledge, none is
induced solely by phage 11. Like PVL, excision/replication of tst-
SaPI68111 was positively correlated with increased TSST-1 gene
transcription. Whether features of SaPI68111 contributed to the
emergence of PVL/TSST-1 co-producing S. aureus remains to be
determined.
Several hypotheses exist to explain the observed specific paired
toxin exclusion in S. aureus. First, exclusion results from
competition for a single chromosome insertion site [45]. However,
this cannot fully explain the mutual exclusion of TSST-1 and PVL
in nearly all S. aureus since, as described above, the chromosomal
location of PVL-carrying phages does not overlap with any
currently reported S. aureus SaPIs including SaPI68111 and
induction of tst-carrying SaPIs requires specific helper phages that
Figure 9. Comparative study of phage induction versus gene transcription in response to mitomycin C or phage 11 treatment. (A.
and B.) Bacteria were treated with mitomycin C (400 ng/ml or 100 ng/ml) for 1 hr. (C. and D.) Freshly prepared phage 11 was added for 1 hr. One
half of samples were used for RNA preparation followed by a quantitative RT-PCR analysis. Fold changes in gene expression of recA, PVL and TSST-1
were normalized to the internal control gene gyrase (Gyr) and relative to no treatment control sample. The other half of samples were used for total
genomic DNA preparation. Relative copy number of TSST-1 or PVL gene versus Gyr were calculated as described in Materials and Methods. Shown is
one representative out of three independent experiments, all of which gave comparable results.
doi:10.1371/journal.pone.0027246.g009
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PLoS ONE | www.plosone.org 9 November 2011 | Volume 6 | Issue 11 | e27246are genetically distinct from PVL-encoding phages. Second,
unknown ‘‘exclusion factors’’ encoded by the first genetic element
block acquisition of the second genetic element [46]. If such factors
exist and mediate toxin exclusion, it would imply that
MSSA68111 is exclusion factor-deficient. Third, one mobile
genetic element commandeers a key bacterial resource essential
for transduction. Fourth, membrane depolarization after infection
by the first element prevents secondary infection [47,48]. Lastly,
defects in the Sau1 restriction modification system may permit
multiple transduction events as has been suggested in S. aureus
RN4220 [49]. Our genetic characterization of MSSA68111 offers
new tools to investigate these possibilities.
In summary, our genetic analysis of a hypervirulent TSST-1/
PVL co-producing CA-MSSA demonstrated that these potent
virulence factors are each carried on unique and fully transmissible
genetic elements. Together these findings portend a possible
worldwide emergence of new hypervirulent S. aureus. Whether
these elements are common among other recently described
TSST-1/PVL co-producing S. aureus, and what their roles may be
in overcoming mutual toxin exclusion, are under investigation.
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